A groundbreaking research initiative at Penn State University is poised to unlock new secrets about nightmares and their intricate relationships with anxiety-related mental health disorders—a move that could ultimately shape how conditions like PTSD are predicted, prevented, and managed worldwide, including in Thailand.
Nightmares, those unsettling nocturnal experiences, are a nearly universal phenomenon among humans and many animals. Yet, the question of why dreams—especially bad ones—occur and what purpose they serve has eluded scientists for centuries. Now, thanks to a three-year, US$1.2 million grant from the W.M. Keck Foundation, an interdisciplinary neuroscience team is taking aim at this enduring mystery. According to principal investigators at Penn State, the study aims to illuminate how nightmares emerge and whether they are a symptom, a cause, or even a warning sign for serious mental health conditions such as post-traumatic stress disorder (PTSD) and anxiety disorders (psu.edu).
Understanding the mechanisms of nightmares goes far beyond academic curiosity. Mental health professionals worldwide, including those in Thailand, have observed that nightmares are a hallmark of illnesses like PTSD—a disorder common not only among war veterans, but also among victims of trauma, road accidents, and childhood abuse. However, as researchers at Penn State point out, it remains an open question whether nightmares are solely a result of trauma or can themselves intensify and perhaps even trigger chronic mental health problems. This distinction, say the scientists, could fundamentally alter the way psychologists and psychiatrists approach prevention and treatment.
The Penn State team, boasting cutting-edge expertise in neural engineering, imaging, biology, and behavioral science, is leveraging a unique approach. They are focusing on the neurological side effects of mefloquine, a drug formerly used to prevent malaria among American soldiers deployed to high-risk regions like Somalia, Afghanistan, and Iraq. While effective against malaria, mefloquine is now rarely prescribed due to its severe neurological side effects—most notably, vivid and disturbing nightmares. By administering the drug to mice, the researchers hope to observe, measure, and map the brain changes that accompany nightmares using advanced imaging techniques and behavioral analysis.
One of the greatest barriers to studying dreams has always been their subjective nature. How can scientists tell if a mouse is experiencing a bad dream, or any dream at all? The Penn State team aims to solve this by deploying innovative neuroimaging, including real-time facial expression and pupil size mapping, fMRI scans, and calcium signal recording, alongside close observation of sleep stages—especially rapid eye movement (REM) sleep, when most vivid dreams and nightmares occur. Through this multi-pronged approach, they seek to pinpoint the specific neuron types and brain circuits involved in nightmare production.
The researchers’ methods also involve monitoring neurotransmitters and neuromodulators, particularly in two brain regions heavily implicated in emotional processing—the prefrontal cortex and the amygdala. By tracking biochemical changes during both nightmares and normal dreaming, the team expects to unearth the elusive connection between disturbed dreaming and disrupted mental health. “Most people believe that nightmares are a consequence of having PTSD, but there is also the possibility that nightmares could exacerbate symptoms or even cause the presence of mental disorders,” explained one of the study’s co-leaders, as cited in the Penn State report.
The ultimate ambition of this research is to develop a predictive framework, using animal models, for mental health disorders based on nightmare patterns. Such a tool could transform mental healthcare, allowing early intervention for individuals at risk of developing anxiety, depression, or PTSD as a result of persistent nightmares. The project also hopes to lay the groundwork for new, non-invasive treatments—possibly including sleep-based interventions—that could alleviate suffering for millions globally.
For Thailand, these findings echo the surging national interest in mental wellbeing, particularly given the rise in reported anxiety and mood disorders since the onset of the COVID-19 pandemic (WHO Thailand). Thai society is deeply attuned to the significance of dreams. In Thai culture, interpretations of dreams—sometimes called “faen,” “sap,” or “khwam fun”—have long woven into local customs, traditional medicine, and even Buddhist thought. While spiritual interpretations remain strong, modern psychiatry is gradually gaining ground as younger Thais seek scientific understanding of their minds. Thailand’s Ministry of Public Health and leading universities, such as Mahidol University and Chulalongkorn University, have established mental health research centers dedicated to studying symptoms like nightmares among at-risk groups, particularly military personnel, police, and survivors of trauma (Mahidol Mental Health Center).
Globally, the link between nightmares and mental health is more than a niche concern. According to a 2020 meta-analysis published in Sleep Medicine Reviews, people with frequent nightmares have a significantly higher risk of developing anxiety and depressive disorders (ScienceDirect). Another study in The Lancet Psychiatry found that treating sleep disturbances in trauma victims can lessen subsequent PTSD severity—a finding that supports the direction of the Penn State research (The Lancet Psychiatry).
Yet challenges remain. Measuring subjective experiences like dreams in animals is notoriously difficult, and their direct relevance to human psychology is always a topic for debate. Nonetheless, foundational biomedical research, especially when supported by robust funding as in the Penn State case, often paves the way for transformative new therapies. “To me, the exciting thing about this research is that we now have a way to gain insight into the purpose of dreams,” commented the project’s principal investigator, highlighting the potential impact of their work on our millennia-old quest to decode the dreaming mind.
As Thailand advances its own healthcare system reforms and invests in early mental health interventions, the country stands to benefit from global insights such as those emerging from Penn State. If scientists can establish reliable indicators—such as frequency or severity of nightmares—as early predictors of future mental health struggles, Thai clinicians could deploy brief, low-cost screening tools within schools, hospitals, and workplaces. This would be particularly valuable in rural provinces, where access to psychiatrists is limited but prevalence of trauma-related disorders remains high, especially among migrant workers, disaster survivors, and those in high-stress occupations.
From a historical viewpoint, Thai society has traditionally turned to Buddhist monks and spiritual healers for psychosocial reassurance after bad dreams. While these roles remain important, there is growing recognition of the need for scientific research, public mental health campaigns, and accessible counseling services. In 2022, Thailand’s Ministry of Public Health designated nightmare-related disturbances among the list of psychosomatic symptoms worthy of national attention (Thai MoPH). This shift signals a blending of traditional wisdom and modern science—a space ripe for the kind of translational research exemplified by the Penn State study.
Looking ahead, if the Penn State team’s efforts yield concrete biomarkers—such as neuroimaging patterns, neurotransmitter fluctuations, or behavioral markers—these discoveries could inspire new diagnostics and treatments adaptable to the Thai healthcare context. For instance, universities and hospitals could incorporate sleep stage monitoring into routine mental health check-ups, or design digital platforms to help individuals track and report nightmare episodes for early intervention. Over time, even local wellness centers and schools might harness these insights for preventative mental healthcare, helping to break taboos and normalize open conversations about mental health.
For the average Thai reader—whether a student, parent, policymaker, or teacher—the next practical step is to pay closer attention to your own sleep patterns and those of your loved ones. If you or someone you know experiences frequent or distressing nightmares, especially following traumatic events, it’s advisable not to brush them aside as mere superstition. Consult with qualified medical professionals or mental health counselors, who can help screen for underlying conditions and suggest evidence-based sleep hygiene practices. Supporting friends and family in seeking help, especially for nightmare or insomnia complaints, is an act of compassion rooted in both Thai tradition and contemporary science.
Above all, this new research is a reminder that dreams—dark or otherwise—are not simply fleeting shadows of sleep, but windows into the brain’s inner workings and emotional resilience. Understanding them could hold the key to transforming mental health care in Thailand and beyond.
Sources: